Articles


Living With Cancer

【知癌知癒】

休克的肝癌患者

Living With Cancer

【知癌知癒】

放射治療助控肝癌 提升病人存活機會

Living With Cancer

【知癌知癒】

肝癌新藥療效佳 有效延長存活期

Living With Cancer

【知癌知癒】慢性肝炎肆虐可致肝癌

New Drug Info

LATITUDE Trial: Adding Abiraterone and Prednisone to Androgen-Deprivation Therapy in Metastatic Castration-Sensitive Prostate Cancer

As reported in the Plenary Session at the 2017 ASCO Annual Meeting and in The New England Journal of Medicine by Fizazi et al, the phase III LATITUDE trial has shown that the addition of abiraterone acetate (Zytiga) and prednisone to androgen-deprivation therapy resulted in marked improvements in overall and progression-free survival in patients with newly diagnosed castration-sensitive metastatic prostate cancer.

Living With Cancer

Bowel cancer: New function of known biomarkers discovered

Living With Cancer

Liver Cancer Facts

Living With Cancer

Liver Cancer Diagnosis

Living With Cancer

Liver Cancer Screening Exams

Living With Cancer

Liver Cancer Symptoms

Living With Cancer

Liver Cancer Treatment

Living With Cancer

Liver Cancer Diagnosis

Living With Cancer

Nanopores could map small changes in DNA that signal big shifts in cancer

Living With Cancer

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques

Living With Cancer

Practical Approach to Triple-Negative Breast Cancer


Next